| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 08/25/2005 | US20050187177 chimeric gene construct composed of a COX-2 promoter operably linked to at least one apoptosis-inducing gene that can cause selectively induced apoptosis in a population of diseased cells; entire classes of cells can be treated with one transfection |
| 08/25/2005 | US20050187156 Isozyme-specific antagonists of protein kinase C |
| 08/25/2005 | US20050187145 template-fixed beta -hairpin peptidomimetics incorporating a template-fixed chain of 7 or 11 alpha -amino acid residues which, depending on their position in the chain, are Gly, or Pro, or of certain types; inhibitors of various serine proteases such as trypsin, human cathepsin G, and thrombin |
| 08/25/2005 | US20050186676 A strain of host cells that contains a temperature sensitive variant of the gene encoding the endonuclease VII from phage T4; a cloning method that selects for PCR products that are devoid of PCR-generated mutations |
| 08/25/2005 | US20050186675 Allelic series of genomic modifications in cells |
| 08/25/2005 | US20050186668 Hormonally up-regulated, neu-tumor-associated kinase |
| 08/25/2005 | US20050186667 nucleotide sequence encoding PNCK that is temporally expressed during postnatal mammary development in a spatially heterogeneous manner in certain subsets of cells, and overexpressed in a subset of primary breast cancers; used as prognostic tools, screening tools and in therapies |
| 08/25/2005 | US20050186666 Protein expression systems |
| 08/25/2005 | US20050186661 Via peptone iv derived from soybean, supplemented with corn steep liquor, beef extract, tryptone, casein, and gelatin; bacteriocin-release-proteins; tolerant to leucine, cysteine, arginine, glycine, asparagine (BDH) and aspartic acid; heat treatment; freeze drying; for use in detergents |
| 08/25/2005 | US20050186659 Methods for protein purification |
| 08/25/2005 | US20050186657 Glycoprotein synthesis |
| 08/25/2005 | US20050186656 Glycoprotein synthesis |
| 08/25/2005 | US20050186649 Inhibitors of human plasmin derived from the kunitz domains |
| 08/25/2005 | US20050186631 Nematode PPPT-like sequences |
| 08/25/2005 | US20050186622 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 08/25/2005 | US20050186618 ADAM gene having a novel base sequence; an ADAM protein encoded by it has the protease activity and is involved in degradation of an extracellular matrix; recombinant vector comprising the DNA; recombinant host cell |
| 08/25/2005 | US20050186617 Transgenic cell comprising vitamin d3 receptor for use as gene expression diagnostic tool which monitor conversion of ligand precursors into ligands |
| 08/25/2005 | US20050186606 Reporter molecule fusion comprising interefering RNA for detection of preferential gene sequences |
| 08/25/2005 | US20050186605 Nucleotide sequences coding thermostable hydrolase for use in enhancing nutrient quality of animal feeds; directed protein evolution |
| 08/25/2005 | US20050186600 Polynucleotides encoding novel UbcH10 polypeptides and kits and methods using same |
| 08/25/2005 | US20050186599 Human protein for use in identifying modulator for diagnosis, drug screening, clinical trial monitoring and treatment of metabolic disorders; cosmetics; nutriceutical |
| 08/25/2005 | US20050186584 Mutant serine/threonine kinase for use as diagnostic indicator of cell proliferative disorders; antiproliferative agents; enzyme inhibitors |
| 08/25/2005 | US20050186583 Linoleate isomerase |
| 08/25/2005 | US20050186574 Anterior gradient 2 homolog (AGR2) for use as to in identifying modulator for treatment of asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, vision defects, inflammatory bowel and cell proliferative disorders |
| 08/25/2005 | US20050186570 Novel n-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor |
| 08/25/2005 | US20050186569 Nucleic acid-associated proteins |
| 08/25/2005 | US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity |
| 08/25/2005 | US20050186564 Production of proteins |
| 08/25/2005 | US20050186219 Transgenic plant-based vaccines |
| 08/25/2005 | US20050186197 Peptide inhibitors of beta lactamases |
| 08/25/2005 | US20050186190 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 08/25/2005 | DE102004007622A1 Preparation of ketocarotenoids, useful in foods and animal feeds, by growing genetically modified organism that has altered activity of ketolase and beta-cyclase |
| 08/25/2005 | DE102004005198A1 Enzymes deposited on a magnetizable carrier, useful particularly for lipase-catalyzed preparation of carboxylate esters, provide easy separation and reuse of enzymes |
| 08/25/2005 | DE102004003410A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae A method for producing L-amino acids using strains of the family Enterobacteriaceae |
| 08/25/2005 | CA2597127A1 Mutation associated with lacunar strokes |
| 08/25/2005 | CA2556245A1 Manufacture of highly phosphorylated lysosomal enzymes and uses thereof |
| 08/25/2005 | CA2556111A1 Method for detecting the risk of cancer, coronary heart disease, and stroke by analysing a catalase gene |
| 08/25/2005 | CA2556088A1 Compositions and methods for modifying the content of polyunsaturated fatty acids in biological cells |
| 08/25/2005 | CA2555675A1 Nicotinamide riboside kinase compositions and methods for using the same |
| 08/25/2005 | CA2555609A1 Expression of plasminogen and microplasminogen in duckweed |
| 08/25/2005 | CA2555415A1 Transgenic corn seed with enhanced amino acid content |
| 08/25/2005 | CA2555393A1 Hybrid proteins of active-site serine beta-lactamase |
| 08/24/2005 | EP1566442A2 Preparation and use of a human antibody gene bank (human antibody libraries) |
| 08/24/2005 | EP1566441A1 Genes coding for hydroxynitrile lyase, recombinant proteins with hydroxynitrile lyase activity and their use |
| 08/24/2005 | EP1566439A1 Preventing or treating obesity |
| 08/24/2005 | EP1566435A1 ROTARY MOTOR MOLECULE V1-ATPase |
| 08/24/2005 | EP1566182A1 Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure |
| 08/24/2005 | EP1565557A2 Mismatch endonucleases and methods of use |
| 08/24/2005 | EP1565554A1 Metabolically engineered micro-organisms having reduced production of undesired metabolic products |
| 08/24/2005 | EP1565553A2 Recombinant catalytic polypeptides and their uses |
| 08/24/2005 | EP1565487A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 08/24/2005 | EP1565209A2 Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1565053A1 Compositions and methods for altering tocotrienol content |
| 08/24/2005 | EP1546335A4 Genetic manipulation of condensed tannins |
| 08/24/2005 | EP1529115A4 Sir2 activity |
| 08/24/2005 | EP1474523A4 Methods of random mutagenesis and methods of modifying nucleic acids using translesion dna polymerases |
| 08/24/2005 | EP1402008B1 Method for purifying an enzyme, a purified enzyme produced thereby, and use of this enzyme |
| 08/24/2005 | EP1358356A4 Dna markers for meat tenderness |
| 08/24/2005 | EP1290150B1 Cutinase variants |
| 08/24/2005 | EP1190248B1 Screening methods for compounds which affect melanogenesis |
| 08/24/2005 | EP1038014B1 VEGETABLE (GntI) SEQUENCES AND THE USE THEREOF TO OBTAIN PLANTS WITH A REDUCED OR LACK OF N-ACETYLGLUCOSAMINYLTRANSFERASE I (GnTI) ACTIVITY |
| 08/24/2005 | EP0906429B1 Cysteine protease promoter from oil seed rape and a method for the containment of plant germplasm |
| 08/24/2005 | EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 08/24/2005 | CN1659283A Bacillus licheniformis mutant host cell |
| 08/24/2005 | CN1659282A Bacillus licheniformis mutant host cell |
| 08/24/2005 | CN1659277A Novel phospholipases and uses thereof |
| 08/24/2005 | CN1659276A Phospholipases, nucleic acids encoding them and methods for making and using them |
| 08/24/2005 | CN1659275A Aldehyde dehydrogenase |
| 08/24/2005 | CN1659271A Improved method for the prevention or reduction of haze in beverages |
| 08/24/2005 | CN1659184A Prothrombin activating protein |
| 08/24/2005 | CN1659180A Novel recombinant anticoagulant proteins |
| 08/24/2005 | CN1657614A System for expressing hyperthermostable protein |
| 08/24/2005 | CN1657613A Method for raising green trichoderma cellulase active by biological surfae active agent |
| 08/24/2005 | CN1657612A Method for preparing solid enzyme preparation from glutamine transminase zymotic fluid |
| 08/24/2005 | CN1657611A Preparation with activities of laccase xylanase, peroxidase and its nucleolide series |
| 08/24/2005 | CN1657603A Mutant microorganism and method for producing peptide using the same |
| 08/24/2005 | CN1657098A Preparation method of earthworm kinase dry powder |
| 08/24/2005 | CN1216149C Cell strain of expression mutation type human tissue plasminogen activator imethod for construction and preparation method of expressing protein |
| 08/24/2005 | CN1216139C Distille's yeast for brewing magma fruit liquor |
| 08/23/2005 | US6934639 Using the three-dimensional structure of human collagenase-3 (MMP-13), a member of the matrix metalloproteinase (MMP) for drug design of MMP-13 inhibitors |
| 08/23/2005 | US6933374 Plant lyase protein for producing taste products, drugs, pigments and hop secondary metabolites; alcoholic beverages |
| 08/23/2005 | US6933369 Mammalian proteinases; oxidoreductases; related reagents |
| 08/23/2005 | US6933367 Protein C or activated protein C-like molecules |
| 08/23/2005 | US6933365 Mutant tyrosine repressor proteins |
| 08/23/2005 | US6933362 Mutant intein made by combination of protein engineering and random mutagenesis that can be used in purification of proteins such as toxic proteins, by inactivation with the intein in a specific region and controllable splicing |
| 08/23/2005 | US6933142 Mammalian glycosylsulfotransferases expressed in high endothelial cells (HEC-GLCNAC6ST) and polypeptides coded by nucleic acids, used for medical diagnosis, drug screening and therapy |
| 08/23/2005 | US6933141 microstructure particles comprising proteins such as savinase or soybean protein; foods; baking; flour; dough; detergents |
| 08/23/2005 | US6933138 Comprises nucleotide sequences coding heat resistant isomerase for preparation of sugar substitute; diabetes preventive agent; detergents and cosmetics additive |
| 08/23/2005 | US6933136 Method for making recombinant proteins |
| 08/23/2005 | US6933132 Regulation of immune responses by attractin |
| 08/23/2005 | US6933127 Substrate for PP2C |
| 08/23/2005 | US6933116 Nucleic acid ligand binding site identification |
| 08/23/2005 | US6933113 Modulation of endogenous gene expression in cells |
| 08/23/2005 | US6932970 administering to a lupus patient a peptide that binds to an anti-double stranded-DNA antibody in the patient, wherein such peptide conataining a D-amino acid sequence of X1-Trp-X1-Tyr-X2, ( X1= Asp or Glu, and X2 = Gly and Ser) |
| 08/23/2005 | US6932965 Separation of deamidated and non-deamidated human dnases and use of the non-deamidated species as a pharmaceutical per se; administering to patients suffering from pulmonary distress |
| 08/23/2005 | CA2258614C Enzymatic esterification process |
| 08/23/2005 | CA2178589C Process for producing l-lysine by fermentation |
| 08/23/2005 | CA2108000C Enhanced gene expression in plants using an hsp70 intron sequence |
| 08/18/2005 | WO2005075675A2 Diagnostics and therapeutics for diseases associated with putative cysteine protease 1 (prs1) |